{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:59:50Z","timestamp":1779375590426,"version":"3.53.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To assess the risk factors for hypotony after sutureless vitrectomy in patients with epiretinal membrane.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This retrospective study enrolled patients with epiretinal membrane who underwent vitrectomy at the Kanazawa Medical University. An intraocular pressure of &lt;5 mmHg on the day after surgery was defined as the hypotony group and the other as the nonhypotony group. Background factors were compared between the two groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This study assessed 126 eyes. Thirteen eyes (10.3%) developed hypotony the day after surgery. Hypotony duration was only the next day for three eyes, within three days for four eyes, 1 week for five eyes, and 2 weeks for one eye. Comparisons between the two groups revealed no substantial differences in age, sex, 25-gauge\/27-gauge, peripheral retinal tear, posterior vitreous detachment, or combined cataract surgery\/vitrectomy alone. Contrastingly, significant differences were found in the axial length (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05) and preoperative glaucoma eye drop use (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). Binary logistic regression analysis revealed that \u2265 26.0 mm axial length (OR 4.577, 95% confidence interval [CI] 1.17 to 17.91, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.03) and preoperative glaucoma eyedrops (OR 7.311, 95% CI 1.47\u201336.45, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01) were significant risk factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Patients with epiretinal membrane with long axial lengths or preoperative glaucoma eye drop treatment should be carefully monitored for hypotony after vitrectomy; nevertheless, most patients spontaneously recover within a week.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004557","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:02:09Z","timestamp":1750179729000},"page":"1900-1907","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["RISK FACTORS FOR HYPOTONY AFTER SUTURELESS VITRECTOMY IN PATIENTS WITH EPIRETINAL MEMBRANE"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7672-9947","authenticated-orcid":false,"given":"Tsuyoshi","family":"Mito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Okemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250917","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/IAE.0000000000000598","article-title":"Comparison of surgical outcome of 23-gauge and 25-gauge microincision vitrectomy surgery for management of idiopathic epiretinal membrane in pseudophakic eyes","volume":"35","author":"Kim","year":"2015","journal-title":"Retina"},{"key":"R2-20250917","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/IAE.0b013e3181cea661","article-title":"Risk factors for the development of transient hypotony after silicone oil removal","volume":"30","author":"Kim","year":"2010","journal-title":"Retina"},{"key":"R3-20250917","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/IAE.0000000000002336","article-title":"Incidence and risk factors for hypotony after 25-gauge pars plana vitrectomy with nonexpansile endotamponade","volume":"40","author":"Mimouni","year":"2020","journal-title":"Retina"},{"key":"R4-20250917","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3928\/15428877-20080301-04","article-title":"Wound leakage and hypotony after 25-gauge sutureless vitrectomy: factors affecting postoperative intraocular pressure","volume":"39","author":"Byeon","year":"2008","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R5-20250917","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/IAE.0b013e318195cb28","article-title":"Risk factors associated with sclerotomy leakage and postoperative hypotony after 23-gauge transconjunctival sutureless vitrectomy","volume":"29","author":"Woo","year":"2009","journal-title":"Retina"},{"key":"R6-20250917","doi-asserted-by":"crossref","first-page":"e0321135","DOI":"10.1371\/journal.pone.0321135","article-title":"Risk factors for hypotony after transconjunctival sutureless vitrectomy","volume":"20","author":"Ando","year":"2025","journal-title":"PLoS One"},{"key":"R7-20250917","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ajo.2010.06.042","article-title":"Hypotony after 25-gauge vitrectomy","volume":"151","author":"Bamonte","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R8-20250917","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/112067210801800419","article-title":"Ultrasound biomicroscopy after vitrectomy in eyes with normal intraocular pressure and in eyes with chronic hypotony","volume":"18","author":"Nehemy","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"R9-20250917","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/IAE.0b013e3181f0d2e6","article-title":"Effect of intravitreal gas tamponade for sutureless vitrectomy wounds: three-dimensional corneal and anterior segment optical coherence tomography study","volume":"31","author":"Yamane","year":"2011","journal-title":"Retina"},{"key":"R10-20250917","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/eye.2015.275","article-title":"Comparative study of 27-gauge vs 25-gauge vitrectomy for epiretinal membrane","volume":"30","author":"Mitsui","year":"2016","journal-title":"Eye (London, England)"},{"key":"R11-20250917","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12886-017-0585-1","article-title":"27-gauge and 25-gauge vitrectomy day surgery for idiopathic epiretinal membrane","volume":"17","author":"Naruse","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"R12-20250917","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10792-019-01250-1","article-title":"Comparison of 27-gauge versus 25-gauge vitrectomy results in patients with epiretinal membrane: 6-month follow-up","volume":"40","author":"Lubi\u0144ski","year":"2020","journal-title":"Int Ophthalmol"},{"key":"R13-20250917","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/archopht.1979.01020010470017","article-title":"Normal and staphylomatous sclera of high myopia. An electron microscopic study","volume":"97","author":"Curtin","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"R14-20250917","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archopht.117.6.794","article-title":"Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway","volume":"117","author":"Sagara","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R15-20250917","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/jop.2019.0146","article-title":"Matrix metalloproteinases and glaucoma treatment","volume":"36","author":"Weinreb","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"key":"R16-20250917","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ophtha.2008.02.001","article-title":"Changes in central corneal thickness over time: the ocular hypertension treatment study","volume":"115","author":"Brandt","year":"2008","journal-title":"Ophthalmology"},{"key":"R17-20250917","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/IJG.0b013e31815d784c","article-title":"Comparison of the effects of latanoprost and bimatoprost on central corneal thickness","volume":"17","author":"Sen","year":"2008","journal-title":"J Glaucoma"},{"key":"R18-20250917","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/jop.2014.0109","article-title":"Long-term effect of latanoprost on central corneal thickness in normal-tension glaucoma: five-year follow-up results","volume":"31","author":"Lee","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"key":"R19-20250917","doi-asserted-by":"crossref","first-page":"9798272","DOI":"10.1155\/2019\/9798272","article-title":"Ocular surface changes in prostaglandin analogue-treated patients","volume":"2019","author":"Shen","year":"2019","journal-title":"J Ophthalmol"},{"key":"R20-20250917","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s00417-019-04435-7","article-title":"Effect of topical prostaglandins on the biomechanics and shape of the cornea","volume":"257","author":"Amano","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R21-20250917","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s12886-020-01693-6","article-title":"The changes of corneal biomechanical properties with long-term treatment of prostaglandin analogue measured by Corvis ST","volume":"20","author":"Wu","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"R22-20250917","first-page":"1514","article-title":"Increased human scleral permeability with prostaglandin exposure","volume":"42","author":"Kim","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-20250917","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1167\/iovs.17-22745","article-title":"Pharmacologic characterization of omidenepag isopropyl, a novel selective EP2 receptor agonist, as an ocular hypotensive agent","volume":"59","author":"Kirihara","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R24-20250917","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3341\/kjo.2021.0169","article-title":"Effect of prostaglandin E2 agonist omidenepag on the expression of matrix metalloproteinase in trabecular meshwork cells","volume":"36","author":"Kim","year":"2022","journal-title":"Korean J Ophthalmol"},{"key":"R25-20250917","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/bjo.2005.086579","article-title":"An experimental study of the elastic properties of the human Bruch's membrane-choroid complex: relevance to ageing","volume":"90","author":"Ugarte","year":"2006","journal-title":"Br J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:01:28Z","timestamp":1758121288000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004557","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}